Breast Cancer
Research from Innsbruck Medical University yields new findings on breast cancer
Published in Surgery Litigation and Law Weekly, November 28th, 2008
According to recent research from Innsbruck, Austria, " To evaluate the impact that pre- and postoperatively administered chemotherapy with cyclophosphamide, methotrexate and fluorouracil (CMF) and postoperative chemotherapy vs. postoperative chemotherapy alone have on long-term prognosis. Patients and Methods The ABCSG conducted a nationwide randomized phase III trial in high-risk endocrine non-responsive breast cancer patients comparing pre- and postoperative chemotherapy containing CMF as preoperative treatment vs. postoperative chemotherapy alone between 1991 and 1999."
"From 1996 the ABCSG-07 protocol was amended to also allow randomization of high-risk...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- AngioDynamics Inc.
AngioDynamics to Launch VenaCure EVLT, New Brand for Varicose Vein Treatment - Biopsy
Advanced Imaging Technologies to Limit Breast and GI Biopsy Procedures - Transplantation
Report summarizes transplantation study findings from University of Florida, Medical Department - Abscess Therapy
Research in the area of abscess therapy reported from University of Pittsburgh, Department of Neurological Surgery - Accuray Incorporated
Accuray Postpones Release of First Quarter Fiscal 2009 Results - Acinar Cell Cancer
Study results from E. Vakiani and colleagues broaden understanding of acinar cell cancer - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
